Recent VNDA News
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation • PR Newswire (US) • 04/22/2024 11:13:00 PM
- Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan • PR Newswire (US) • 04/17/2024 02:21:00 PM
- Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak • PR Newswire (US) • 04/17/2024 01:02:00 PM
- Biotech Catches Major Premarket Bid Following FDA Approval • AllPennyStocks.com • 04/03/2024 02:25:00 PM
- Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder • PR Newswire (US) • 04/02/2024 10:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:31:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:50:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:48:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:47:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:00 PM
- Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:14:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:12:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:10:28 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:08:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:06:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:52:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:50:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:32:11 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:31:12 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/08/2024 12:19:14 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM